This is my take on Zimmer's CEO stepdown:
1. got rid of the incompetent captain of the ship.
2. replace the shitty trabecular metal products line full of recalls & lawsuits.
3. Add the superior, one of a kind si3n4 super biomaterial to help them to maintain & gain more market shares.
4. Later add the new, better captain (CEO) to guide the ship into the right direction.
5. On the 27th, they have to report a lousy 2Q for sure. In order to save the day on that conference call, they must have "something" very special to announce to their investors like acquiring a company with special type of biomaterial Si3N4, which later lead to increase in huge amount of revenues for the company. The tutes that are holding their shares will find no reason not to approve the underway acquisition of that little company "Amedica".
==============================================================
1. R/S = no time as Boston already covered that on a few previous posts.
2. OTC? WTF ... Backward? so much milestones completed...and finally go list on loosely regulated market? Illogical!
3. BK = really? paid debt down from $36 Mils to around $3.5 Mils (included July payment) while revenue jumps. 0% chance.
4. Hercules default (not late or payment issue) on non timely to deliver Financial Statement per the loan agreement. NO "BITCHING" from Hercules & no 8K to update investors that they ask waiver from Hercules = never have to worry/ or don't have to ask for waiver from Hercules.
5. Not worry about delisting deadline (as no time for R/S; how to fix over $1 price by August 14th?)
6. NO 8K to update investors about what plan they submitted to Nasdaq (accepted, rejected, pending result).
There is only 1 scenario that will resolve all of the above issues .......SELLING THE COMPANY!
